| Zacin 0.025% w/w Cream PA23369/005/001 |
Capsaicin |
Ennogen Healthcare (Europe) Limited |
Marketed |
| ZADENVI 60 mg solution for injection in pre-filled syringe EU/1/25/1937/001 |
Denosumab |
Zentiva k.s. |
— |
| Zaditen 0.25 mg/ml, eye drops, solution PA1107/010/001 |
KETOTIFEN FUMARATE |
Laboratoires Thea |
Marketed |
| Zaditen 1 mg Tablets PA2206/004/002 |
KETOTIFEN FUMARATE |
Alfasigma S.p.A |
Marketed |
| Zaditen 1mg/5ml oral solution PA2206/004/001 |
Ketotifen hydrogen fumarate |
Alfasigma S.p.A |
Marketed |
| Zafrilla 2mg tablets PA1330/023/001 |
Dienogest |
Gedeon Richter Plc |
Marketed |
| Zalasta 10 mg Orodispersible tablet EU/1/07/415/42-46 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 10 mg Tablet EU/1/07/415/16-21 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 15 mg Orodispersible tablet EU/1/07/415/47-51 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 15 mg Tablet EU/1/07/415/22-26 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 2.5 mg Tablet EU/1/07/415/1-5 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 20 mg Orodispersible tablet EU/1/07/415/52-56 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 20 mg Tablet EU/1/07/415/27-31 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 5 mg Orodispersible tablet EU/1/07/415/32-36 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 5 mg Tablet EU/1/07/415/006 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 7.5 mg Orodispersible tablet EU/1/07/415/37-41 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| Zalasta 7.5 mg Tablet EU/1/07/415/11-15 |
Olanzapine |
KRKA, d.d., Novo mesto |
— |
| ZALTRAP 25 mg/ml concentrate for solution for infusion EU/1/12/814/001-003 |
Aflibercept |
Sanofi Winthrop Industrie |
— |
| Zanaflex 2 mg Tablets PA0749/054/001 |
Tizanidine |
Teva Pharma B.V. |
Marketed |
| Zanaflex 2 mg Tablets PPA0465/474/001 |
Tizanidine |
PCO Manufacturing Ltd. |
— |
| Zanaflex 2 mg Tablets PPA1463/224/001 |
Tizanidine |
IMED Healthcare Ltd. |
— |
| Zanaflex 4 mg Tablets PA0749/054/002 |
Tizanidine |
Teva Pharma B.V. |
Marketed |
| Zanaflex 4 mg Tablets PPA0465/474/002 |
Tizanidine |
PCO Manufacturing Ltd. |
— |
| Zanaflex 4 mg Tablets PPA1463/224/002 |
Tizanidine |
IMED Healthcare Ltd. |
— |
| Zanidip 10 mg film-coated tablets PA0812/001/001 |
Lercanidipine hydrochloride |
Recordati Industria Chimica e Farmaceutica SpA |
Marketed |
| Zanidip 10 mg film-coated tablets PPA0465/481/001 |
Lercanidipine hydrochloride |
PCO Manufacturing Ltd. |
Not marketed |
| Zanidip 10 mg film-coated tablets PPA1463/203/001 |
Lercanidipine hydrochloride |
IMED Healthcare Ltd., |
— |
| ZANIDIP 10 mg Film-coated Tablets PPA23080/034/001 |
Lercanidipine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| Zanidip 20 mg film-coated tablets PPA0465/481/002 |
Lercanidipine hydrochloride |
PCO Manufacturing Ltd. |
— |
| Zanidip 20 mg film-coated tablets PPA1463/203/002 |
Lercanidipine hydrochloride |
IMED Healthcare Ltd., |
— |
| ZANIDIP 20 mg Film-coated Tablets PPA23080/034/002 |
Lercanidipine hydrochloride |
Merit Pharmaceuticals Limited |
— |
| Zanidip 20mg film-coated tablets PA0812/001/002 |
Lercanidipine hydrochloride |
Recordati Industria Chimica e Farmaceutica SpA |
Marketed |
| Zarontin 250 mg/5 ml Syrup PA22644/005/001 |
Ethosuximide |
Essential Pharma (M) Limited |
Marketed |
| Zarontin 250 mg/5 ml Syrup PPA0465/456/001 |
Ethosuximide |
PCO Manufacturing Ltd. |
— |
| Zarontin 250 mg/5 ml Syrup PPA1463/181/001 |
Ethosuximide |
IMED Healthcare Ltd., |
— |
| Zarontin 250mg/5ml Syrup PPA2306/031/001 |
Ethosuximide |
Originalis B.V. |
— |
| Zarzio 30 MU (60 MU/ml) Solution for injection or EU/1/08/495/1-4,9-12 |
Ep2006 (recombinant human granulocyte-colony stimulating factor) |
Sandoz GmbH |
— |
| Zarzio 48 MU (96 MU/ml) Solution for injection or EU/1/08/495/5-8,13-16 |
Ep2006 (recombinant human granulocyte-colony stimulating factor) |
Sandoz GmbH |
— |
| Zavedos 1 mg/ml solution for injection PA0822/142/005 |
Idarubicin hydrochloride |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Zavesca 100 mg capsules EU/1/02/238/001 |
Miglustat |
Janssen-Cilag International NV |
— |
| Zavicefta 2 g/0.5 g powder for concentrate for solution for infusion EU/1/16/1109/001 |
Avibactam sodium, Ceftazidime pentahydrate |
Pfizer Ireland Pharmaceuticals |
— |
| Zebinix 200 mg Tablet EU/1/09/514/021-023 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 400 mg Tablet EU/1/09/514/1-6 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 50 mg/ml Oral suspension EU/1/09/514/024 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 600 mg Tablet EU/1/09/514/7-11 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 800 mg Tablet EU/1/09/514/12-20 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zedbac 500 mg powder for concentrate for solution for infusion PA23142/010/001 |
Azithromycin dihydrate |
Aspire Pharma (Malta) Limited |
Not marketed |
| Zeffix 100 mg Film-coated tablet EU/1/99/114/001 |
Lamivudine |
GlaxoSmithKline Trading Services Limited |
— |
| Zeffix 100 mg Film-coated tablet EU/1/99/114/002 |
Lamivudine |
GlaxoSmithKline Trading Services Limited |
— |
| Zeffix 5 mg/ml Oral solution EU/1/99/114/003 |
Lamivudine |
GlaxoSmithKline Trading Services Limited |
— |